Regulations and procedures in parasite vaccine development

Parasitology

Volumn 133, Issue SUPPL.2, 2006, Pages

  Schetters, Th P M ^a   Gravendyck, M ^b  

^a Parasitology R and D Department   (Netherlands)

^b Intervet International   (Netherlands)

Author keywords

Development; Guidelines; Manufacture; Parasite; Requirements; Vaccine

Indexed keywords

INACTIVATED VACCINE; LIVE VACCINE; SAPONIN; SUBUNIT VACCINE; TETRACYCLINE; VACCINE;

COCCIDIOSIS; DRUG EFFICACY; DRUG POTENCY; DRUG QUALITY; DRUG SAFETY; EUROPEAN UNION; GIARDIASIS; IMMUNITY; LAW; LEISHMANIASIS; LICENSING; LIFE CYCLE; MARKETING; MEDICINE; NONHUMAN; PARASITE; PARASITOSIS; PRIORITY JOURNAL; PROTOZOAL INFECTION; RESEARCH; REVIEW; THEILERIA PARVA; UNITED STATES;

ANIMALS; EUROPEAN UNION; EVIDENCE-BASED MEDICINE; HUMANS; PROTOZOAN VACCINES; QUALITY CONTROL; RESEARCH; SAFETY; TREATMENT OUTCOME; UNITED STATES; VACCINATION; VACCINES, ATTENUATED;

EID: 33846828592     PISSN: 00311820     EISSN: 14698161     Source Type: Journal    
DOI: 10.1017/S0031182006001879     Document Type: Review

References (23)

1. Brunko, P. (1997). Part 3. Procedures and technical requirements in the European Union. In Veterinary Vaccinology (ed. Pastoret, P.-P., Blancou, J., Vannier, P. and Verschueren, C.), pp. 674-679. Elsevier, Amsterdam.
2. Buxton, D. (1993). Toxoplasmosis: the first commercial vaccine. Parasitology Today 9, 335-337.
3. Cornelissen, A. W. C. A. and Schetters, Th. P. M. (1996). Vaccines against protozoal diseases of veterinary importance. FEMS Immunology and Medical Microbiology 15, 61-72.
4. Dalton, J. P. and Mulcahy, G. (2001). Parasite vaccines - A reality ? Veterinary Parasitology 98, 149-167.
5. De Waal, D. T. and Combrink, M. P. (2006). Live vaccines against babesiosis. Veterinary Parasitology 138, 88-96.
6. Espeseth, D. (1997). Part 4. Procedures and norms in the United States. In Veterinary Vaccinology (ed. Pastoret, P.-P., Blancou, J., Vannier, P. and Verschueren, C.), pp. 680-686. Elsevier, Amsterdam.
7. Harrison, G. B., Shakes, T. R., Robinson, C. M., Lawrence, S. B., Heath, D. D., Dempster, R. P., Lightowlers, M. W. and Rickard, M. D. (1999). Duration of immunity, efficacy and safety in sheep of a recombinant Taenia ovis vaccine formulated with saponin or selected adjuvants. Veterinary Immunology and Immunopathology 20, 161-172.
8. Marcotty, T., Billiouw, M., Chaka, G., Berkvens, D., Losson, B. and Brandt, J. (2001). Immunisation against East Coast Fever by the infection and treatment method: evaluation of the use of ice baths for field delivery and appraisal of an acid formulation of long-acting tetracycline. Veterinary Parasitology 99, 175-187.
9. Noguiera, F. S., Moreira, M. A. B., Borja-Cabrera, G. P., Santos, F. N., Menz, I., Parra, L. E., Xu, Z., Chu, H. J., Palatnik-de-Sousa, C. B. and Luvizotto, M. C. R. (2005). Leishmune® vaccine blocks the transmission of canine visceral leishmaniasis. Absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs. Vaccine 23, 4805-4810.
10. Olson, M. E., Ceri, H. and Morck, D. W. (2000). Giardia vaccination. Trends in Parasitology 16, 213-217.
11. Schetters, Th. P. M. (1995). Vaccine development from a commercial point of view. Veterinary Parasitology 57, 267-275.
12. Schetters, Th. P. M. (2004). Intervet Symposium Bovine Neosporosis. Veterinary Parasitology 125, 137-146.
13. Schetters, Th. P. M. (2005). Vaccination against canine babesiosis. Trends in Parasitology 21, 179-184.
14. Schijns, V. E. and Tangeras, A. (2005). Vaccine adjuvant technology: from theoretical mechanisms to practical approaches. Developmental Biology 121, 127-134.
15. Shkap, V. and Pipano, E. (2000). Culture-derived parasites in vaccination of cattle against tick-borne diseases. Annals of the New York Academy of Sciences 916, 154-171.
16. Sutkowsky, E. M. and Gruber, M. F. (2006). Regulatory considerations in the non-clinical safety assessment of adjuvanted preventive vaccines. In Immunopotentiators in Modern Vaccines (ed. Schijns, V. E. J. C. and O'Hagan, D. T.), pp. 343-359. Elsevier Academic Press, London.
17. Urquhart, G. M. (1985). Field experience with the bovine lungworm vaccine. Developments in Biological Standardization 62, 109-112.
18. Vercruysse, J., Knox, D. P., Schetters, Th. P. M. and Willadsen, P. (2004). Veterinary parasitic vaccines: Pitfalls and future directions. Trends in Parasitology 20, 488-492.
19. Vermeulen, A. N., Schaap, D. C. and Schetters, Th. P. M. (2001). Control of coccidiosis in chickens by vaccination. Veterinary Parasitology 100, 13-20.
20. Wallach, M., Smith, N. C., Petracca, M., Miller, C. M. D., Eckert, J. and Braun, R. (1995). Eimeria maxima gametocyte antigens: Potential use in a subunit maternal vaccine against coccidiosis in chickens. Vaccine 13, 347-354.
21. Willadsen, P. (2004). Anti-tick vaccines. Parasitology 129 (Suppl.), S367-S387.
22. Williams, R. B. (1994). Safety of the attenuated anticoccidial vaccine Paracox in broiler chickens isolated from extraneous coccidial infection. Veterinary Research Communications 18, 189-198.
23. Williams, R. B. (2002). Anticoccidial vaccines for broiler chickens: pathways to success. Avian Pathology 31, 317-353. Review (2003); Erratum in Avian Pathology 32, 429.